Cart
sales@molnova.com
Ibandronic acid
CAS No. 114084-78-5
Ibandronic acid( —— )
Catalog No. M10495 CAS No. 114084-78-5
Ibandronic acid is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 29 | In Stock |
|
| 25MG | 33 | In Stock |
|
| 50MG | 37 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIbandronic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionIbandronic acid is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.
-
DescriptionIbandronic acid is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHBV
-
RecptorHAP| FPPS
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number114084-78-5
-
Formula Weight319.23
-
Molecular FormulaC9H23NO7P2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESCCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Entecavir
Entecavir(BMS200475; SQ34676) is a guanosine analogue that inhibits reverse transcription, DNA replication and transcription in the viral replication process; oral antiHBV drug.
-
ccc_R08
ccc_R08 is an orally available HBV cccDNA inhibitor that reduces extracellular levels of HBV DNA, HBsAg, and HBeAg in a dose-dependent manner. ccc_R08 is investigational for use in the treatment of HBV infections. ccc_R08 has been shown to be effective in the treatment of hepatitis C virus (HCV).
-
Lagociclovir
Lagociclovir (MIV-210), a nucleoside analogue, is an antiviral compound available for the treatment of HBV82 that inhibits the replication of wild-type hepatitis B virus (HBV) in human hepatocellular carcinoma cell lines that permanently express HBV.
